Suppr超能文献

伽玛刀放射外科治疗难治性脉络丛乳头状瘤。

Gamma knife radiosurgery for treatment resistant choroid plexus papillomas.

作者信息

Kim In-Young, Niranjan Ajay, Kondziolka Douglas, Flickinger John C, Lunsford L Dade

机构信息

Department of Neurological Surgery, Center for Image-Guided Neurosurgery, Medical Center-Presbyterian, University of Pittsburgh, 200 Lothrop Street, Suite B-400, Pittsburgh, PA 15213, USA.

出版信息

J Neurooncol. 2008 Oct;90(1):105-10. doi: 10.1007/s11060-008-9639-9. Epub 2008 Jun 28.

Abstract

OBJECTIVE

To report the results of gamma knife radiosurgery (GKR) for treatment resistant choroid plexus papillomas.

METHODS

Six patients (median age 55 years; range 29-75) with residual (n = 2) or recurrent (n = 4) choroid plexus papillomas underwent GKR. All failed prior surgery and one failed prior proton beam radiation therapy. These six patients had a total of 11 locally or distant recurrent intracranial tumors. The median and mean tumor volumes were 2.7 and 3.9 cc (range, 0.23-21.1). A median margin dose of 12.0 Gy (range, 11.5-15) was prescribed to the tumor margin.

RESULTS

The progression-free periods varied from 7 to 108 months (mean: 36.9). Four tumors were stable after GKR but seven showed progression. Four recurrent tumors in two patients were managed with repeat radiosurgery and three were observed. At the second GKR, the tumor volume varied from 1.3 to 12.4 cc, and the marginal radiation dose varied from 11 to 14 Gy. The overall survival after the first GKR varied from 15 to 120 months. Four patients were alive at the end of the study period.

CONCLUSIONS

Radiosurgery represents an additional management strategy for patients who progress despite surgical removal. It may especially be useful for patients with small deep seated residual choroid plexus papillomas, and for tumors that recur at a site distant from their origin.

摘要

目的

报告伽玛刀放射外科治疗(GKR)耐药性脉络丛乳头状瘤的结果。

方法

6例(中位年龄55岁;范围29 - 75岁)残留(n = 2)或复发(n = 4)的脉络丛乳头状瘤患者接受了GKR治疗。所有患者先前手术均失败,1例先前质子束放射治疗失败。这6例患者共有11处局部或远处复发性颅内肿瘤。肿瘤的中位体积和平均体积分别为2.7 cc和3.9 cc(范围,0.23 - 21.1)。肿瘤边缘的中位边缘剂量为12.0 Gy(范围,11.5 - 15)。

结果

无进展生存期从7个月到108个月不等(平均:36.9个月)。4例肿瘤在GKR后病情稳定,但7例出现进展。2例患者的4处复发性肿瘤接受了重复放射外科治疗,3处进行了观察。在第二次GKR时,肿瘤体积从1.3 cc到12.4 cc不等,边缘放射剂量从11 Gy到14 Gy不等。首次GKR后的总生存期从15个月到120个月不等。在研究期结束时,4例患者存活。

结论

对于尽管手术切除仍病情进展的患者,放射外科是一种额外的治疗策略。它可能对深部小残留脉络丛乳头状瘤患者以及在远离原发部位复发的肿瘤患者特别有用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验